skip to main content
Idioma:
Mostrar Somente
Refinado por: assunto: Biological And Medical Sciences remover Antibiotics. Antiinfectious Agents. Antiparasitic Agents remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial
Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial

Kasahara, Akinori ; Hayashi, Norio ; Hiramatsu, Naoki ; Oshita, Masahide ; Hagiwara, Hideki ; Katayama, Kazuhiro ; Kato, Michio ; Masuzawa, Manabu ; Yoshihara, Harumasa ; Kishida, Yutaka ; Shimizu, Yoji ; Inoue, Atsuo ; Fusamoto, Hideyuki ; Kamada, Takenobu

Hepatology (Baltimore, Md.), 1995-02, Vol.21 (2), p.291-297 [Periódico revisado por pares]

Philadelphia, PA: W.B. Saunders

Texto completo disponível

Citações Citado por
2
Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50
Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50
Material Type:
Artigo 		Adicionar ao Meu Espaço

Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50

HANAKI, H ; KUWAHARA-ARAI, K ; BOYLE-VAVRA, S ; DAUM, R. S ; LABISCHINSKI, H ; HIRAMATSU, K

Journal of antimicrobial chemotherapy, 1998-08, Vol.42 (2), p.199-209 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
3
Age and total ribavirin dose are independent predictors of relapse after interferon therapy in chronic hepatitis C revealed by data mining analysis
Age and total ribavirin dose are independent predictors of relapse after interferon therapy in chronic hepatitis C revealed by data mining analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Age and total ribavirin dose are independent predictors of relapse after interferon therapy in chronic hepatitis C revealed by data mining analysis

KUROSAKI, Masayuki ; HIRAMATSU, Naoki ; NAKAGAWA, Mina ; YATSUHASHI, Hiroshi ; IZUMI, Namiki ; SAKAMOTO, Minoru ; SUZUKI, Yoshiyuki ; IWASAKI, Manabu ; TAMORI, Akihiro ; MATSUURA, Kentaro ; KAKINUMA, Sei ; SUGAUCHI, Fuminaka ; SAKAMOTO, Naoya

Antiviral therapy, 2012, Vol.17 (1), p.35-43 [Periódico revisado por pares]

London: International Medical Press

Texto completo disponível

Citações Citado por
4
Antibacterial activity of 2,4-diacetylphloroglucinol produced by Pseudomonas sp. AMSN isolated from a marine alga, against vancomycin-resistant Staphylococcus aureus
Antibacterial activity of 2,4-diacetylphloroglucinol produced by Pseudomonas sp. AMSN isolated from a marine alga, against vancomycin-resistant Staphylococcus aureus
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antibacterial activity of 2,4-diacetylphloroglucinol produced by Pseudomonas sp. AMSN isolated from a marine alga, against vancomycin-resistant Staphylococcus aureus

ISNANSETYO, Alim ; LONGZHU CUI ; HIRAMATSU, Keiichi ; KAMEI, Yuto

International journal of antimicrobial agents, 2003-11, Vol.22 (5), p.545-547 [Periódico revisado por pares]

London: Elsevier

Texto completo disponível

Citações Citado por
5
Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus
Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus

FUKUDA, H ; HORI, S ; HIRAMATSU, K

Antimicrobial agents and chemotherapy, 1998-08, Vol.42 (8), p.1917-1922 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

Citações Citado por
6
Antimicrobial susceptibilities and analysis of genes related to penicillin or macrolide resistance in Streptococcus pneumoniae
Antimicrobial susceptibilities and analysis of genes related to penicillin or macrolide resistance in Streptococcus pneumoniae
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antimicrobial susceptibilities and analysis of genes related to penicillin or macrolide resistance in Streptococcus pneumoniae

Hiramatsu, Kazufumi ; Ohama, Minoru ; Mijajima, Yoshiko ; Kishi, Kenji ; Mizunoe, Syunji ; Tokimatsu, Issei ; Nagai, Hiroyuki ; Kadota, Jun-ichi ; Saikawa, Tetsunori ; Nasu, Masaru

International journal of antimicrobial agents, 2004-08, Vol.24 (2), p.125-129 [Periódico revisado por pares]

London: Elsevier B.V

Texto completo disponível

Citações Citado por
7
Certification of the critical importance of L-3-(2-naphthyl)alanine at position 3 of a specific CXCR4 inhibitor, T140, leads to an exploratory performance of its downsizing study
Certification of the critical importance of L-3-(2-naphthyl)alanine at position 3 of a specific CXCR4 inhibitor, T140, leads to an exploratory performance of its downsizing study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Certification of the critical importance of L-3-(2-naphthyl)alanine at position 3 of a specific CXCR4 inhibitor, T140, leads to an exploratory performance of its downsizing study

TAMAMURA, Hirokazu ; OMAGARI, Akane ; FUJII, Nobutaka ; HIRAMATSU, Kenichi ; OISHI, Shinya ; HABASHITA, Hiromu ; KANAMOTO, Taisei ; GOTOH, Kazuyo ; YAMAMOTO, Naoki ; NAKASHIMA, Hideki ; OTAKA, Akira

Bioorganic & medicinal chemistry, 2002-05, Vol.10 (5), p.1417-1426 [Periódico revisado por pares]

Oxford: Elsevier Science

Texto completo disponível

Citações Citado por
8
Characterization of Staphylococci with Reduced Susceptibilities to Vancomycin and Other Glycopeptides
Characterization of Staphylococci with Reduced Susceptibilities to Vancomycin and Other Glycopeptides
Material Type:
Artigo 		Adicionar ao Meu Espaço

Characterization of Staphylococci with Reduced Susceptibilities to Vancomycin and Other Glycopeptides

TENOVER, F. C ; LANCASTER, M. V ; HILL, B. C ; STEWARD, C. D ; STOCKER, S. A ; HANCOCK, G. A ; O'HARA, C. M ; CLARK, N. C ; HIRAMATSU, K

Journal of Clinical Microbiology, 1998-04, Vol.36 (4), p.1020-1027 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

Citações Citado por
9
Clindamycin Modulates Inflammatory-Cytokine Induction in Lipopolysaccharide-Stimulated Mouse Peritoneal Macrophages
Clindamycin Modulates Inflammatory-Cytokine Induction in Lipopolysaccharide-Stimulated Mouse Peritoneal Macrophages
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clindamycin Modulates Inflammatory-Cytokine Induction in Lipopolysaccharide-Stimulated Mouse Peritoneal Macrophages

NAKANO, Tetsuji ; HIRAMATSU, Kazufumi ; KISHI, Kenji ; HIRATA, Norio ; KADOTA, Jun-Ichi ; NASU, Masaru

Antimicrobial Agents and Chemotherapy, 2003-01, Vol.47 (1), p.363-367 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

Citações Citado por
10
Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1β
Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1β
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1β

KISHI, K ; HIRAI, K ; HIRAMATSU, K ; YAMASAKI, T ; NASU, M

Antimicrobial agents and chemotherapy, 1999-03, Vol.43 (3), p.616-622 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (46)

Data de Publicação 

De até
Refinar
  1. Antes de1996  (4)
  2. 1996Até1998  (12)
  3. 1999Até2001  (14)
  4. 2002Até2005  (10)
  5. Após 2005  (10)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.